South Carolina General Assembly
123rd Session, 2019-2020

Download This Bill in Microsoft Word format

Indicates Matter Stricken
Indicates New Matter

H. 4711

STATUS INFORMATION

General Bill
Sponsors: Rep. Fry
Document Path: l:\council\bills\cc\15602vr20.docx

Introduced in the House on January 14, 2020
Currently residing in the House Committee on Medical, Military, Public and Municipal Affairs

Summary: Naloxone

HISTORY OF LEGISLATIVE ACTIONS

     Date      Body   Action Description with journal page number
-------------------------------------------------------------------------------
  11/20/2019  House   Prefiled
  11/20/2019  House   Referred to Committee on Medical, Military, Public and 
                        Municipal Affairs
   1/14/2020  House   Introduced and read first time (House Journal-page 75)
   1/14/2020  House   Referred to Committee on Medical, Military, Public and 
                        Municipal Affairs (House Journal-page 75)

View the latest legislative information at the website

VERSIONS OF THIS BILL

11/20/2019

(Text matches printed bills. Document has been reformatted to meet World Wide Web specifications.)

A BILL

TO AMEND THE CODE OF LAWS OF SOUTH CAROLINA, 1976, BY ADDING SECTION 44-53-361 SO AS TO REQUIRE PRESCRIBERS TO OFFER A PRESCRIPTION FOR NALOXONE TO A PATIENT UNDER CERTAIN CIRCUMSTANCES AND FOR OTHER PURPOSES.

Be it enacted by the General Assembly of the State of South Carolina:

SECTION    1.        Article 3, Chapter 53, Title 44 of the 1976 Code is amended by adding:

   

    "Section 44-53-361.    (A)    A prescriber shall do the following:

        (1)    offer a prescription for naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression to a patient when one or more of the following conditions are present:

            (a)    the prescription dosage for the patient is ninety or more morphine milligram equivalents of an opioid medication per day;

            (b)    an opioid medication is prescribed concurrently with a prescription for benzodiazepine; or

            (c)    the patient presents with an increased risk for overdose, including a patient with a history of overdose, a patient with a history of substance use disorder, or a patient at risk for returning to a high dose of opioid medication to which the patient is no longer tolerant;

        (2)    consistent with the existing standard of care, provide education to patients receiving a prescription pursuant to item (1) on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression; and

        (3)    consistent with the existing standard of care, provide education on overdose prevention and the use of naloxone hydrochloride or another drug approved by the United States Food and Drug Administration for the complete or partial reversal of opioid depression to one or more persons designated by the patient, or, for a patient who is a minor, to the minor's parent or guardian.

    (B)    A prescriber who fails to offer a prescription, as required by subsection (A)(1), or fails to provide the education and use information required by subsections (A)(2) and (3) must be referred to the appropriate licensing board solely for the imposition of administrative sanctions deemed appropriate by that board. This section does not create a private right of action against a prescriber, and does not limit a prescriber's liability for the negligent failure to diagnose or treat a patient."

SECTION    2.    This act takes effect upon approval by the Governor.

----XX----


This web page was last updated on January 16, 2020 at 11:08 AM